# A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

> **NCT00002140** · PHASE3 · COMPLETED · sponsor: **Pfizer**

## Conditions studied

- Mycobacterium Avium-intracellulare Infection
- HIV Infections

## Interventions

- **DRUG:** Ethambutol hydrochloride
- **DRUG:** Clarithromycin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00002140
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002140, "A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00002140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*